Total hip arthroplasty: A review of advances, advantages and limitations

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 1, 2015, Pages 27-36

  Liu, Xin Wei ^a   Zi, Ying ^b   Xiang, Liang Bi ^a   Wang, Yu ^a  

^a GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

^b Chinese People's Liberation Army 463 Hospital   (China)

Author keywords

Hip arthroplasty; Osteoarthritis; Quality of life

Indexed keywords

POLYETHYLENE;

ARTHRALGIA; ARTHROPATHY; CEMENTED PROSTHESIS; CEMENTLESS PROSTHESIS; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; DISTRESS SYNDROME; EXERCISE; HUMAN; IMAGING; INFLAMMATION; JOINT CAVITY; JOINT IMAGING; JOINT SPACE NARROWING; LIFE EXPECTANCY; OSTEOARTHRITIS; OSTEOLYSIS; PATIENT ASSESSMENT; PELVIC PAIN; PHYSICAL ACTIVITY; POSTTHROMBOSIS SYNDROME; QUALITY OF LIFE; RADIOGRAPHY; REVIEW; SEXUAL BEHAVIOR; SEXUAL FUNCTION; SURVIVAL RATE; TOTAL HIP PROSTHESIS; TREATMENT OUTCOME;

EID: 84922976784     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Daras M, Macaulay W. Total hip arthroplasty in young patients with osteoarthritis. Am J Orthop (Belle Mead NJ) 2009; 38: 125-9.
2. Dorr LD, Luckett M, Conaty JP. Total hip arthroplasties in patients younger than 45 years: A nine- to ten-year follow-up study. Clin Orthop 1990; 260: 215-219.
3. Callaghan JJ, Forest EE, Sporer SM, Goetz DD, Johnston RC. Total hip arthroplasty in the young adult. Clin Orthop 1997; 344: 257-262.
4. Berry DJ, Harmsen WS, Cabanela ME, Morrey BF. Twenty-five-year survivorship of two thousand consecutive primary Charnley total hip replacements: Factors affecting survivorship of acetabular and femoral components. J Bone Joint Surg Am 2002; 84: 171-177.
5. Cornell CN, Ranawat CS. Survivorship analysis of total hip replacements: Results in a series of active patients who were less than fifty-five years old. J Bone Joint Surg Am 1986; 68: 1430-1434.
6. Boeree NR, Bannister GC. Cemented total hip arthroplasty in patients younger than 50 years of age: 10- to 18-year results. Clin Orthop 1993; 287: 153-159.
7. Sochart DH, Porter ML. The long-term results of Charnley low-friction arthroplasty in young patients who have congenital dislocation, degenerative osteoarthrosis, or rheumatoid ar-thritis. J Bone Joint Surg Am 1997; 79: 1599-1617.
8. Hartofilakidis G, Karachalios T, Karachalios G. The 20-year outcome of the Charnleyarth-roplasty in younger and older patients. Clin Orthop 2005; 434: 177-182.
9. Devitt A, O’Sullivan T, Quinlan W. 16- to 25-year follow-up study of cemented arthroplasty of the hip in patients aged 50 years or younger. J Arthroplasty 1997; 12: 479-489.
10. Kim YH, Oh SH, Kim JS. Primary total hip arthroplasty with a second-generation cementless total hip prosthesis in patients younger than fifty years of age. J Bone Joint Surg Am 2003; 85: 109-14.
11. Eskelinen A, Remes V, Helenius I, Pulkkinen P, Nevalainen J, Paavolainen P. Uncemented total hip arthroplasty for primary osteoarthritis in young patients: A mid- to long-term follow-up study from the Finnish Arthroplasty. Register Acta Orthop 2006; 77: 57-70.
12. D’Antonio JA, Capello WN, Manley MT, Geesink R. Hydroxyapatite femoral stems for total hip arthroplasty: 10- to 13-year followup. Clin Orthop 2001; 393: 101-111.
13. Engh CA Jr, Culpepper WJ, Engh CA. Long-term results of use of the anatomic medullary locking prosthesis in total hip arthroplasty. J Bone Joint Surg Am 1997; 79: 177-84.
14. Clohisy JC, Harris WH. Primary hybrid total hip replacement, performed with insertion of the acetabular component without cement and a precoat femoral component with cement: an average ten-year follow-up study. J Bone Joint Surg Am 1999; 81: 247-255.
15. Bizot P, Hannouche D, Nizard R, Witvoet J, Sedel L. Hybrid alumina total hip arthroplasty using a press-fit metal-backed socket in patients younger than 55 years: A six- to 11-year evaluation. J Bone Joint Surg Br 2004; 86: 190-194.
16. Digas G, Kärrholm J, Thanner J, Malchau H, Herberts P. Highly cross-linked polyethylene in cemented THA: Randomized study of 61 hips. Clin Orthop 2003; 417: 126-138.
17. Urban JA, Garvin KL, Boese CK, Bryson L, Pedersen DR, Callaghan JJ, Miller RK. Ceramic-on-polyethylene bearing surfaces in total hip arthroplasty: Seventeen to twenty-one-year results. J Bone Joint Surg Am 2001; 83: 1688-1694.
18. Dorr LD, Wan Z, Longjohn DB, Dubois B, Murken R. Total hip arthroplasty with use of the Metasul metal-on-metal articulation: Four to seven-year results. J Bone Joint Surg Am 2000; 82: 789-798.
19. Weidow J, Mars I, Karrholm J. Medial and lateral osteoarthritis of the knee is related to variations of hip and pelvic anatomy. Osteo-arthritis Cartil 2005; 13: 471-477.
20. Shakoor N, Hurwitz DE, Block JA, Shott S, Case JP. Asymmetric knee loading in advanced unilateral hip osteoarthritis. Arthritis Rheum 2003; 48: 1556-1561.
21. Englund M, Lohmander LS. Risk factors for symptomatic knee osteoarthritis Wfteen to twenty-two years after meniscectomy. Arthritis Rheum 2004; 50: 2811-2819.
22. McGrory BJ, Morrey BF, Cahalan TD, An KN, Cabanela ME. Effect of femoral oVset on range of motion and abductor muscle strength after total hip arthroplasty. J Bone Joint Surg 1995; 77B: 865-869.
23. Mäkelä K, Eskelinen A, Pulkkinen P, Paavo-lainen P, Remes V. Cemented total hip replacement for primary osteoarthritis in patients aged 55 years or older: Results of the 12 most common cemented implants followed for 25 years in the Finnish Arthroplasty Register. J Bone Joint Surg Br 2008; 90: 1562-1569.
24. Berry DJ, Harmsen WS, Cabanela ME, Morrey BF. Twenty-five-year survivorship of two thousand consecutive primary Charnley total hip replacements: Factors effecting survivorship of acetabular and femoral components. J Bone Joint Surg Am 2002; 84-A: 171-177.
25. Malchau H, Herbert P, Eisler T, Garellick G, Soderman P. The Swedish Total Hip Replace-ment Register. J Bone Joint Surg Am 2002; 84-A: 2-20.
26. Mäkelä KT, Eskelinen A, Pulkkinen P, Paavolainen P, Remes V. Total hip arthroplasty for primary osteoarthritis in patients 55 years of age or older: An analysis of the Finnish Arthroplasty Register. J Bone Joint Surg Am 2008: 90-A: 2160-2170.
27. Meding JB, Keating EM, Ritter MA, Faris PM, Berend ME. Minimum ten-year follow-up of a straight-stemmed, plasma-sprayed, titanium-alloy, cementless femoral component in primary total hip arthroplasty. J Bone Joint Surg Am 2004; 86: 92-97.
28. Oosterbos CJ, Rahmy AI, Tonino AJ, Witpeerd W. High survival rate of hydroxyapatite-coated hip prostheses: 100 consecutive hips followed for 10 years. Acta Orthop Scand 2004; 75: 127-133.
29. Parvizi J, Keisu KS, Hozack WJ, Sharkey PF, Rothman RH. Primary total hip arthroplasty with an uncemented femoral component: A long-term study of the Taperloc stem. J Arthroplasty 2004; 19: 151-156.
30. Havelin LI, Espehaug B, Engesaeter LB. The performance of two hydroxyapatite-coatedacetabularcups. From the Norwegian Arthroplasty Register. J Bone Joint Surg Br 2002; 84: 839-845.
31. Bhan S, Pankaj A, Malhotra R. One- or two-stage bilateral total hip arthroplasty: A prospective, randomised, controlled study in an Asian population. J Bone Joint Surg Br 2006; 88: 298-303.
32. Reuben JD, Meyers SJ, Cox DD, Elliott M, Watson M, Shim SD. Cost comparison between bilateral simultaneous, staged, and unilateral total joint arthroplasty. J Arthroplasty 1998; 13: 172-179.
33. Tarity TD, Herz AL, Parvizi J, Rothman RH. Ninety-day mortality after hip arthroplasty: A comparison between unilateral and simultaneous bilateral procedures. J Arthroplasty 2006; 21: 60-64.
34. Crawford RW, Murray DW. Total hip replacement: Indications for surgery and risk factors for failure. Ann RheumDis 1997; 56: 455-457.
35. Croft P, Cooper C, Wickham C, Coggon D. Defining osteoarthritis of the hip for epidemiologic studies. Am J Epidemiol 1990; 132: 514-522.
36. Dougados M, Gueguen A, Nguyen M, Berdah L, Lequesne M, Mazieres B, Vignon E. Radiological progression of hip osteoarthritis definition, risk factors and correlations with clinical status. Ann Rheum Dis 1996; 55: 356-362.
37. Nilsdotter AK, Aurell Y, Siosteen AK, Lohmander LS, Roos HP. Radiographic stage of osteosarthritis or sex of the patient does not predict one year outcome after total hip arthroplasty. Ann Rheum Dis 2001; 60: 228-232.
38. Fortin PR, Clarke AE, Joseph L, Liang MH, Tanzer M, Ferland D. Outcomes of total hip and knee replacement. Arthritis Rheum 1999; 42: 1722-1728.
39. Hoaglund F, Oishi C, Giallamas G. Exterme variations in racial rates of total hip arthroplasty for primary coxartrosis: A population based study in San Francisco. Ann Rheum Dis 1995; 54: 107-110.
40. Martel W, Adler RS, chan K, Nikalson L, Helvie MA, Jonsson K. Overview: New methods in imaging osteoarthritis. J Rheumatol 1991; 18: 32-37.
41. Conrozier T, Jousseaume CA, Mathieu P, Tron AM, Caton J, Bejui J, Vignon E. Quantitative measurement of joint space narrowing progression in hip osteoarthritis: A longitudinal retrospective study of patients treated by total hip arthroplasty. Br J Rheumatol 1998; 37: 961-968.
42. Gabriel S, Wenger D, Ilstrup D, Lewallen D, Melton J. Lack of evidence of gender bias in the utilization of total hip arthroplasty among Olmsted County, Minnesota residents with osteoarthritis. Arthiritis Rheum 1994; 8: 1171-1176.
43. Fitzgerald SJ, McAndrew CM, Kraay MJ, Goldberg VM. Incidence of postthrombotic syndrome in patients undergoing primary total hip arthroplasty for osteoarthritis. Clin Orthop Relat Res 2011; 469: 530-534.
44. Bernardi E, Prandoni P. The post-thrombotic syndrome. Curr Opin Pulm Med 2000; 4: 335-342.
45. Kahn SR. Measurement properties of the Villalta scale to define and classify the severity of the post-thrombotic syndrome. J Thromb Haemost 2009; 5: 884-888.
46. Brandjes DP, Buller HR, Heijboer H, Huisman MV, de Rijk M, Jagt H. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997; 9054: 759-762.
47. Sasaki K, Senda M, Nishida K, Ota H. Preo-perative time required for the timed “up and go” test in women with hip osteoarthritis could predictba deep venous thrombosis complication after total hip arthroplasty. Acta Med 2010; 64: 197-201.
48. Knutsson S, BergbomEngberg I. An evaluation of patients’ quality of life before, 6 weeks and 6 months after total hip replacement surgery. J Adv Nurs 1999; 30: 1349-1359.
49. Hunt SM, Mc Kenna SP, Mc Ewen J, Williams J, Papp E. The Nottingham Health Profile: Subjective health statusand medical consultations. Soc Sci Med 1981; 15A: 221-229.
50. Bergner M, Bobbitt RA, Pollard WE, Martin DP, Gilson BS. The Sickness Impact Profile: Validation of a health status measure. Med Care 1976; 14: 57-67.
51. Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36). Med Care 1992; 30: 473-483.
52. Bellamy N. Instruments to assess osteoarthritis-current status and future needs. Ann Rheum Dis 1995; 54: 692-693.
53. Laupacis A, Bourne R, Rorabeck C, Feeny D, Wong C, Tugwell P. The effect of elective total hip replacement on health-related quality of life. J Bone Joint Surg Am 1993; 75: 1619.
54. Katz JN, Phillips CB, Fossel AH, Liang MH. Stability and responsiveness of utility measures. Med Care 1994; 32: 183.
55. James M, St Leger S, Rowsell KV. Prioritising elective care: A cost utility analysis of orthopaedics in the northwest of England. J Epidemiol Community Health 1996; 50: 182.
56. Robinson AH, Palmer CR, Villar RN. Is revision as good as primary hip replacement? A comparison of quality of life. J Bone Joint Surg Br 1999; 81: 42.
57. Feeny D, Blanchard C, Mahon JL, Bourne R, Rorabeck C, Stitt L. Comparing community-preference-based and direct standard gambleutility scores: Evidence from elective total hip arthroplasty. Int J Technol Assess Health Care 2003; 19: 362.
58. Räsänen P, Paavolainen P, Sintonen H, Koivisto AM, Blom M, Ryynänen OP. Effectiveness of hip or knee replacement surgery in terms of qualityadjusted life years and costs. Acta Orthop 2007; 78: 108.
59. Chang RW, Pellissier JM, Hazen GB. A cost effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip. JAMA 1996; 275: 858-865.
60. Liang MH, Cullen KE, Larson MG, Thompson MS, Schwartz JA, Fossel AH. Cost effective-ness of total joint arthroplasty in osteoarthritis. Arthritis Rheum 1986; 29: 937-943.
61. Kaplan RM, Bush JV, Berry CC. Health status: Types of validity and the index of well being. Health Serv Res 1976; 4: 478-507
62. Laupacis A, Bourne R, Rorabeck C, Feeny D, Wong C, Tugwell P, Leslie K, Bullas R. Costs of elective hip arthroplasty during the first year. J Arthroplasty 1994; 9: 481-7.
63. Ritter MA, Meding JB. Total hip arthroplasty. Can the patient play sports again? Orthopedics 1987; 10: 1447-1452.
64. Zahiri CA, Schmalzried TP, Szuszczewicz ES, Amstutz HC. Assessing activity in joint replacement patients. J Arthroplasty 1998; 13: 890-5.
65. Norman-Taylor FH, Palmer CR, Villar RN. Quality-of-life improvement compared after hip and knee replacement. J Bone Joint Surg Br 1996; 78: 74-77.
66. Wang BL, Yue DB, Liu BX, Guo WS. Quality of sexual life after total hip arthroplasty in male patients with osteonecrosis of femoral head. Eur J Orthop Surg Traumatol 2014; 24: 1217-21.
67. Soong M, Rubash HE, Macaulay W. Dislocation after total hip arthroplasty. J Am Acad Orthop Surg 2004; 12: 314-21.
68. Lindeque B, Hartman Z, Noshchenko A, Cruse M. Infection after primary total hip arthroplasty. Orthopedics 2014; 37: 257-65.